Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Acupressure in Patients With Sickle Cell Disease

NCT: NCT06511453 · ACTIVE_NOT_RECRUITING

NCT IDNCT06511453
StatusACTIVE_NOT_RECRUITING
Start Date2024-03-07
Completion2032-05

Brief Summary

The proposed research is to determine the clinical efficacy and neurobiological mechanisms of acupressure analgesia in patients with sickle cell disease (SCD).

Frequently Asked Questions

What is Acupressure in Patients With Sickle Cell Disease?

Acupressure in Patients With Sickle Cell Disease is a clinical trial registered under NCT06511453. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06511453?

The current status of NCT06511453 (Acupressure in Patients With Sickle Cell Disease) is: ACTIVE_NOT_RECRUITING.

When did Acupressure in Patients With Sickle Cell Disease start?

Acupressure in Patients With Sickle Cell Disease started on 2024-03-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.